Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Cash Conversion Cycle

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Days.

The item "Cash-Conversion-Cycle" stands at 174.53 days as of 09/30/2025.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Cash Conversion Cycle" stands at 174.53 Days. This represents an increase of 3.10 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.67 percent compared to the value the year prior.
The 1 year change in percent is -12.67.
The 3 year change in percent is 24.85.

The Serie's long term average value is 169.80 days. It's latest available value, on 09/30/2025, is 2.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +60.42%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -30.29%.

Cash Conversion Cycle for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Conversion Cycle905,699,262,464.00
LogoJohnson & Johnson - Cash Conversion Cycle486,508,953,600.00
LogoAbbVie Inc - Cash Conversion Cycle399,570,305,024.00
LogoRoche Holding AG - Cash Conversion Cycle317,433,206,677.55
LogoAstraZeneca PLC - Cash Conversion Cycle280,205,508,085.11